AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

Switglim-M 3mg/500mg Tablet PR

Prescription Icon
Prescription Required

Marketer

Akumentis Healthcare Ltd

Salt Composition

Glimepiride (3mg) + Metformin (500mg)

Overview Switglim-M 3mg/500mg Tablet PR

DiaBeta-Duo 3mg/500mg tablets are classified as antidiabetic agents, combining two medications to manage type 2 diabetes in adults. This medication aids in regulating blood glucose levels. DiaBeta-Duo 3mg/500mg tablets should be ingested with food, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continuous use is crucial, even with controlled blood sugar or feeling well; discontinuation without medical consultation risks elevated blood glucose, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan, incorporating a balanced diet, regular exercise, and weight management as recommended by your doctor. Lifestyle choices significantly influence diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect; familiarize yourself with its symptoms (sweating, dizziness, headache, tremors) and appropriate countermeasures. Regular meals and readily available fast-acting glucose sources (sugary foods or juice) are essential. Alcohol consumption should be minimized due to its potential to exacerbate hypoglycemia. Additional potential side effects include altered taste perception, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may occur in some individuals. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe kidney or liver dysfunction. Prior heart conditions should be disclosed to your physician before commencing treatment. Consult your doctor before use during pregnancy or breastfeeding. Regular blood glucose monitoring is necessary, and your doctor may recommend blood tests to track blood cell counts and liver function.

Uses of Switglim-M 3mg/500mg Tablet PR

Managing Type 2 Diabetes

Major Benefits of Switglim-M 3mg/500mg Tablet PR:

Always follow your physician's instructions or consult the product label for usage guidelines. Consume Switglim-M 3mg/500mg Tablet PR with a meal.

Common Side effects of Switglim-M 3mg/500mg Tablet PR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Switglim-M 3mg/500mg Tablet PR:

Follow your physician's instructions or consult the product label for dosage information. Consume Switglim-M 3mg/500mg Tablet PR with a meal.

How Switglim-M 3mg/500mg Tablet PR works:

Each Switglim-M 3mg/500mg tablet contains glimepiride (a sulfonylurea) and metformin (a biguanide), two medications that manage blood sugar. Glimepiride stimulates the pancreas to release more insulin, thus reducing blood glucose levels. Metformin acts by decreasing liver glucose production, slowing intestinal glucose absorption, and enhancing insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol use with Switglim-M 3mg/500mg tablets is contraindicated.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Switglim-M 3mg/500mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescribing this medication. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Lactation and the use of Switglim-M 3mg/500mg tablets are incompatible. Evidence indicates a potential for infant harm from this medication.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Exercise caution when administering Switglim-M 3mg/500mg Tablet PR to individuals with impaired renal function; dosage modification may be necessary. Consult a physician for guidance. Switglim-M 3mg/500mg Tablet PR is contraindicated in patients exhibiting severe kidney disease. Close monitoring of kidney function is recommended during treatment.

LiverLiverCAUTION

Caution is advised when prescribing Switglim-M 3mg/500mg Tablet PR to individuals with hepatic impairment. Dosage modifications for Switglim-M 3mg/500mg Tablet PR may be necessary. Physician consultation is recommended. Initiation of Switglim-M 3mg/500mg Tablet PR therapy typically begins with a reduced dose in patients exhibiting mild to moderate liver dysfunction; however, its use is contraindicated in those with severe liver disease.

What if you forget to take Switglim-M 3mg/500mg Tablet PR :

Should you forget a dose of Switglim-M 3mg/500mg Tablet PR, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Switglim-M 3mg/500mg Tablet PR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Switglim-M 3mg/500mg Tablet PR

Store this medication in its original, tightly closed container as directed on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Switglim-M 3mg/500mg Tablet PR can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as Metformin-associated lactic acidosis or MALA). This rare but potentially harmful side effect is more likely in patients with kidney disease, the elderly, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Switglim-M 3mg/500mg Tablet PR and seek immediate medical attention.
Switglim-M 3mg/500mg tablets combine glimepiride and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood sugar control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 diabetes.
Switglim-M 3mg/500mg Tablet PR may cause common side effects including hypoglycemia, altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects such as lactic acidosis are also possible. Prolonged use may result in vitamin B12 deficiency.
Prolonged use of Switglim-M 3mg/500mg Tablet PR can lead to vitamin B12 deficiency by impairing its absorption. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in the extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Switglim-M 3mg/500mg Tablet PR can cause hypoglycemia (low blood sugar), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, and anxiety or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice, at all times.
Combining Switglim-M 3mg/500mg tablets with alcohol is unsafe. Alcohol can worsen the drug's blood sugar-lowering effects, potentially causing hypoglycemia and increasing the risk of lactic acidosis.
Switglim-M 3mg/500mg Tabl...
94
MRP 109
13% off